Chugai and Fuji Pharma enter agreement over cancer drug

05-09-2016

Chugai and Fuji Pharma enter agreement over cancer drug

Pressmaster / shutterstock.com

Chugai Pharmaceutical and Fuji Pharma  have entered into an agreement to transfer the rights to the manufacture and marketing of cancer drug Vesanoid (tretinoin) in Japan.


Chugai, Fuji Pharma, Vesanoid, tretinoin

LSIPR